###begin article-title 0
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
The effect of deletion of the orphan G - protein coupled receptor (GPCR) gene MrgE on pain-like behaviours in mice
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 181 186 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 311 316 311 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 414 419 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 450 455 450 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mrgs </italic>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
The orphan GPCR MrgE is one of an extended family of GPCRs that are expressed in dorsal root ganglia (DRG). Based on these expression patterns it has been suggested that GPCRs like MrgE may play a role in nociception however, to date, no direct supporting evidence has emerged. We generated mutant mice lacking MrgE and examined the effects of deletion of this gene in three pain behavioural models. The effect of MrgE gene deletion on expression of Mrgs and genes involved in sensory neurone function was also investigated.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE</italic>
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mrg </italic>
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 365 369 365 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgF</italic>
###xml 504 508 504 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE</italic>
###xml 537 542 537 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
The absence of MrgE had no effect on the development of pain responses to a noxious chemical stimulus or an acute thermal stimulus. However, in contrast, the development but not the maintenance of neuropathic pain was affected by deletion of MrgE. The expression of Mrg genes was not significantly affected in the MrgE knockout (KO) mice with the sole exception of MrgF. In addition, the expression of 77 of 84 genes involved in sensory neuron development and function was also unaffected by deletion of MrgE. Of the 7 genes affected by MrgE deletion, 4 have previously been implicated in nociception.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
The data suggests that MrgE may play a role in selective pain behavioural responses in mice.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 40 41 40 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgC</italic>
###xml 430 435 430 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgC </italic>
###xml 492 493 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 732 733 732 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 782 787 782 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgC </italic>
###xml 902 907 902 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgC </italic>
###xml 911 916 911 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgA </italic>
###xml 1064 1065 1064 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1133 1138 1133 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgD </italic>
###xml 1275 1276 1275 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1574 1575 1574 1575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1694 1695 1694 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 486 490 <span type="species:ncbi:10116">rats</span>
###xml 561 567 <span type="species:ncbi:9913">Bovine</span>
###xml 898 901 <span type="species:ncbi:10116">rat</span>
###xml 1110 1114 <span type="species:ncbi:10090">mice</span>
###xml 1229 1233 <span type="species:ncbi:10090">mice</span>
###xml 1621 1624 <span type="species:ncbi:10116">rat</span>
Mrg-receptors, first described in 2001 [1], constitute a family of G-protein coupled receptors in which certain members are expressed in distinct subsets of sensory neurons, known to play a role in nociception, and were activated by peptides that had previously been functionally linked to pain. Indirect physiological evidence for a role for MrgC, in particular, was provided by the demonstration that peptides known to activate MrgC elicited pain-like behaviours on administration to rats [2]. Recently it has been shown that levels of one of these peptides, Bovine Adrenal Medulla peptide 22, was increased in superficial laminae of the spinal cord (SC) and in DRG cells following complete freunds adjuvant induced inflammation [3]. However the specificity of these peptides for MrgC has not been conclusively demonstrated, therefore non-MrgC mediated effects cannot be ruled out. Expression of rat MrgC and MrgA is down regulated in DRG following spinal nerve ligation provided additional evidence that these receptors are somehow functionally linked to pain [4]. Elegant studies with genetically modified mice demonstrated that MrgD is uniquely expressed in primary afferent nerve fibres but pain behavioural phenotypes for mice lacking this receptor were not reported [5]. The MrgD ligand, beta-alanine, inhibited potassium channel mediated M-current activity in both a recombinant cell system and primary DRG neurons suggesting that activation of MrgD could inhibit the M-current resulting in repetitive firing of normally phasic nociceptive neurons leading to pain [6]. Similarly activation of MrgX1 expressed in rat superior cervical ganglion neurons resulted in M-current inhibition [7].
###end p 9
###begin p 10
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 347 353 <span type="species:ncbi:10090">Murine</span>
A functional role for Mrg receptors in other systems could be assumed from the physiological functions of ligands known to activate these receptors. MrgX2 is activated by basic molecules [8] and cortistatin [9], amongst other ligands, and is therefore postulated to have a role in mast cell degranulation and neuroendocrine function respectively. Murine MrgA1 and MrgC11 are activated by RF-amide peptides [10] suggesting that these receptors could be involved in a variety of neuromodulatory functions attributed to these peptides [11]. However, as with pain, direct physiological proof for a role for these receptors in these systems is lacking.
###end p 10
###begin p 11
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 377 381 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE</italic>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 516 521 516 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 617 621 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mrgs</italic>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
Study of members of this family is generally hampered by the lack of specific ligands and/or pharmacological tools. MrgE is an orphan receptor; however we and others have demonstrated that this receptor is largely restricted to the nervous system with greatest expression in SC and DRG [12]. In the absence of suitable tools we have developed genetically modified mice lacking MrgE. The phenotype of MrgE KO mice was studied in a number of assays, with particular focus on pain behaviours. The effect of deletion of MrgE on expression of a selection of genes known to be expressed in sensory neurons, including other Mrgs, was also investigated.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Generation of MrgE KO mice
###end title 13
###begin p 14
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 322 327 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 412 417 412 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 483 488 483 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 530 535 530 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 553 554 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 210 215 <span type="species:ncbi:10090">mouse</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
MrgE KO mice were generated using a standard homologous recombination strategy. Southern blot confirmed homologous recombination had occurred (data not shown) and a PCR genotyping strategy was used to genotype mouse tail DNA samples (see Fig. 1). The genotype of the MrgE KO animals was confirmed by absence of detectable MrgE transcripts in all tissues tested. TaqMan quantitative PCR confirmed the presence of MrgE expression in DRG, SC and brain from wild-type (WT) mice; whereas MrgE expression was not detected in homozygote MrgE KO mice (see Fig. 2).
###end p 14
###begin p 15
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Gene targeting strategy for generation of <italic>MrgE </italic>KO mice</bold>
###xml 266 271 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 764 769 764 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 1000 1005 1000 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
Gene targeting strategy for generation of MrgE KO mice. (A) The targeting vector was assembled on the pGT-N28 backbone (NEB, Ipswich, MA) and so designed such that a total of 776 base pairs from within the 930 base pair coding region located in exon 2 of the 2 exon MrgE gene (first exon is un-translated) was deleted and replaced with a 7,076 base pair IRES-lacZ reporter and neomycin resistance cassette. Solid Line: intron 1; boxes colored red: exons 1 and 2; box colored blue: coding sequence located in exon 2; uncoloured box: IRES-LacZ-NEO cassette replacing part of the coding sequence located in exon 2; black triangle: FRT sequence. (B) Genotyping assay was designed to differentiate among wild type (+/+), heterozygote (+/-) or homozygote knockout (-/-) MrgE mice and performed using a multiplex PCR reaction, with a shared 5' forward primer (5'-GCA GAC ATC AGC CAT GAC GT-3') and a 3' reverse primer unique to the targeted allele (#2416, 5'-ATC AGC TTA CCA TGG CCA AGA TCC C-3') or to the MrgE locus (5'-ATC TAT CTC TTG GAT GTG GCC TG-3'). The WT amplicon is 201 and KO allele 922 bps.
###end p 15
###begin p 16
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mrg </italic>
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Quantitative RTPCR analysis of <italic>Mrg </italic>expression</bold>
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mrg </italic>
###xml 187 192 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
Quantitative RTPCR analysis of Mrg expression. Quantitative RTPCR analysis of Mrg expression in (A) DRG and (B) SC and brain from WT and KO mice. The asterisks indicate that no copies of MrgE were detected.
###end p 16
###begin title 17
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Behavioural testing of KO and WT mice
###end title 17
###begin p 18
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
KO and WT mice were subjected to a battery of behavioural and biochemical tests. KO mice appeared to be normal in the majority of tests with some minor differences noted in blood biochemistry, sexual behaviour and prepulse startle responses. However no overt phenotypic abnormalities were identified (Data not shown).
###end p 18
###begin p 19
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
The locomotor activity of mice was assessed demonstrating no difference in the general motor coordination of WT and KO mice (see Fig. 3).
###end p 19
###begin p 20
###xml 0 36 0 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Locomotor activity of WT and KO mice</bold>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Locomotor activity of WT and KO mice. Data is Mean +/- SEM of 3-4 mice per group expressed as activity counts per 5 minute bin intervals for 1 hour. No significant effect was seen between the groups over the time course.
###end p 20
###begin p 21
###xml 94 99 94 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
Intraplantar injection of formalin resulted in a biphasic nocifensive response in both WT and MrgE KO mice (see Fig. 4). There was a trend towards reduced nocifensive behaviours in the KO mice in the first phase of the response to formalin (see Fig. 4C); however this did not reach statistical significance. Overall, no significant difference in the frequency or timing of nocifensive behaviours between WT and KO mice was detected in either the first or second phase of the formalin test. Likewise, hotplate responses of WT and KO mice were similar (data not shown)
###end p 21
###begin p 22
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 0 36 0 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Formalin test of WT and <italic>MrgE </italic>KO mice</bold>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
Formalin test of WT and MrgE KO mice. (A) The time course of development of formalin responses in KO and WT mice. (B) The early and late phase of the formalin response in KO and WT mice showing a trend towards reduction in early phase behaviours in KO mice.
###end p 22
###begin p 23
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
KO and WT mice developed ipsilateral punctate allodynia after chronic constriction injury (CCI) of the sciatic nerve. A statistically significant difference in the rate of development of allodynia was demonstrated between WT and MrgE KO mice (see Fig. 5). The onset of maximal allodynia was delayed in the KO in comparison to the WT mice, with the most significant difference in allodynia noted in the day 2 to 7 period post surgery. Otherwise, the WT and MrgE KO mice maintained a similar level of allodynia indicated by a paw withdrawal threshold of 0.04 g or less. The onset of recovery at approximately 100 days post surgery was also similar in both groups.
###end p 23
###begin p 24
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Chronic constriction injury of WT and <italic>MrgE </italic>KO mice</bold>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
Chronic constriction injury of WT and MrgE KO mice. The punctuate allodynia data are expressed as median force (g) required to induce a PWT in wild-type (n = 13) and KO (n = 6) mice (vertical bars represent the first and third quartiles). ***P < 0.01, *P < 0.05 unpaired T Test comparing WT and KO mice at each time point.
###end p 24
###begin title 25
Gene expression analysis
###end title 25
###begin p 26
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mrg </italic>
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgD </italic>
###xml 236 238 236 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E </italic>
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mrgs </italic>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 295 300 295 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 321 325 321 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mrg </italic>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 461 467 461 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgC11</italic>
###xml 469 470 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 472 473 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 475 476 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 478 480 478 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H </italic>
###xml 484 488 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PR4 </italic>
###xml 529 534 529 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgF </italic>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 609 616 609 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgC11 </italic>
###xml 620 622 620 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 734 742 734 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgPRa4 </italic>
###xml 745 750 745 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgG </italic>
###xml 824 826 824 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 999 1010 999 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFR &#945;-2</italic>
###xml 1012 1014 1008 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Na</italic>
###xml 1014 1015 1010 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink">v</italic>
###xml 1014 1015 1010 1011 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>v</italic></sub>
###xml 1015 1018 1011 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1.7</italic>
###xml 1020 1022 1016 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Na</italic>
###xml 1022 1023 1018 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">v</italic>
###xml 1022 1023 1018 1019 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>v</italic></sub>
###xml 1023 1026 1019 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1.8</italic>
###xml 1032 1039 1028 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx-1 </italic>
###xml 1079 1080 1075 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
###xml 1064 1068 <span type="species:ncbi:10090">mice</span>
The expression of Mrg gene family members together with genes important for sensory neuron function and development were examined in various tissues from adult WT and MrgE KO mice by quantitative RTPCR analysis. In WT animals, MrgD and E are the most abundant Mrgs in DRG (see Fig. 2A); whereas MrgE is the most abundant Mrg in SC and brain with 6000 and 3000 arbitrary copies respectively (see Fig. 2B). There is no statistical difference in the expression of MrgC11, D, F, G, H and PR4 genes in DRG of KO and WT mice. However, MrgF is up-regulated 2-fold (p = 0.0013) in the SC of KO animals (see Fig. 2B). MrgC11 and D expression was detected at extremely low levels in brain and SC preparations from some, but not all, mice while MrgPRa4 or MrgG expression was not detected in brain or SC (data not shown). Use of the RT2 PCR profiler array (SuperArray) consisting of genes implicated in patterning, development and/or function of sensory neurones revealed a trend towards reduced expression of GFR alpha-2, Nav1.7, Nav1.8, and Runx-1 in DRG from KO versus WT mice (see Fig. 6) (p = <0.05, p = *0.07).
###end p 26
###begin p 27
###xml 0 108 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Quantitative RTPCR analysis of DRG expression of genes involved in sensory neuron function in WT and KO mice</bold>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Quantitative RTPCR analysis of DRG expression of genes involved in sensory neuron function in WT and KO mice. RT2 arrays revealed several sensory neurone genes were reduced in DRG of the KO relative to WT animals (p = <0.05, p = *0.07). Error bars represent standard deviation.
###end p 27
###begin p 28
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 275 276 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 107 110 <span type="species:ncbi:10116">rat</span>
The effect of chronic constriction injury of the sciatic nerve on MrgE gene expression was examined in the rat. Expression of MrgE in the injured sciatic nerve relative to the uninjured sciatic nerve was significantly reduced at all time points post surgery tested (see Fig. 7).
###end p 28
###begin p 29
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Quantitative RTPCR analysis of <italic>MrgE </italic>expression post CCI in the rat</bold>
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 63 66 <span type="species:ncbi:10116">rat</span>
###xml 144 148 <span type="species:ncbi:10116">rats</span>
Quantitative RTPCR analysis of MrgE expression post CCI in the rat. MrgE expression was reduced in ipsi-versus contralateral sciatic nerve from rats 7, 14 and 21 days post CCI surgery (n = 6 per time point) (Error bars represent standard deviation P < 0.01). Expression of MrgE in ipsi- and contralateral sciatic nerve from naive animals was unchanged (data not shown).
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 197 203 197 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgD </italic>
###xml 235 241 235 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgA1 </italic>
###xml 503 507 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE</italic>
###xml 612 616 612 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mrgs</italic>
###xml 768 773 768 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgD </italic>
###xml 777 779 777 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E </italic>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 333 338 <span type="species:ncbi:10090">mouse</span>
MrgE KO and WT mice are indistinguishable in the formalin and hotplate tests implying that MrgE plays no significant role in the response to noxious chemical and thermal stimuli respectively. Dong et al 2001 demonstrated that MrgD and MrgA1 are expressed in vanniloid receptor-1 (VR1) negative small diameter sensory neurones in the mouse, indicating that these receptors may be less important for the detection of noxious chemical stimuli. At present the detailed distribution of other Mrgs, including MrgE, in rodent DRG has not been determined. Taken together, the KO and distribution data would suggest that Mrgs, in general, may not be involved in the sensing of chemically induced pain, although this may not be the case for higher mammals where distribution of MrgD and E in VR1 positive and medium to large diameter neurones, respectively, was detected in DRG [13].
###end p 31
###begin p 32
###xml 319 324 319 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 464 469 464 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 519 524 519 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 620 625 620 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 830 835 830 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 870 875 870 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 616 619 <span type="species:ncbi:10116">rat</span>
###xml 1092 1096 <span type="species:ncbi:10090">mice</span>
There was a significant difference between WT and KO mice in the rate they develop an increased hypersensitivity to the application of von Frey hairs. However the peak level of allodynia acquired, and maintained, was similar in both WT and KO mice. The slower rate of onset of allodynia in the KO animals suggests that MrgE plays a role in the development but not the maintenance of allodynia. Whether this behavioural effect is directly due to lack of functional MrgE in adult mice or has arisen due to the absence of MrgE during the development of the nervous system in KO animals remains to be seen. In the adult rat MrgE expression is significantly reduced as early as day 7 post CCI of the sciatic nerve lending further support to the notion that this gene may be involved in the development of allodynia. Down regulation of MrgE or a reduction in cells expressing MrgE may be an essential component of the temporal processes that affect the development of allodynia, therefore the complete absence of this gene deregulates these processes slowing the development of allodynia in the KO mice.
###end p 32
###begin p 33
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
Emerging data and hypotheses suggest that cellular and functional plasticity involving neuro-immune interaction and neuronal long term facilitation, potentiation and depression in the periphery, at spinal and/or supraspinal sites may underlie behaviours such as allodynia associated with persistent pain states (For recent reviews see [14,15]). Although MrgE is expressed at all tissue levels known to be involved in pain sensation, the KO data suggests that it has no role in maintaining the long term plastic changes that may underlie neuropathic pain. This notion is supported by the observation that KO and WT animals develop the same degree of allodynia.
###end p 33
###begin p 34
###xml 535 547 535 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFR &#945;-2 </italic>
###xml 548 550 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 551 553 547 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Na</italic>
###xml 553 554 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">v</italic>
###xml 553 554 549 550 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>v</italic></sub>
###xml 554 558 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1.7 </italic>
###xml 559 561 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 562 564 558 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Na</italic>
###xml 564 565 560 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">v</italic>
###xml 564 565 560 561 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>v</italic></sub>
###xml 565 569 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1.8 </italic>
###xml 570 572 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 573 575 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 581 588 577 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx-1 </italic>
###xml 589 591 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 719 724 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 596 600 <span type="species:ncbi:10090">mice</span>
The small but statistically significant down regulation of genes known to be involved in sensory neuron function and development is of interest and may also offer an explanation. It is tempting to speculate that reduction in the expression of these genes observed in the DRG of KO mice may reflect a reduction in the number of neurons that express these same genes. The loss of these sensory neurons may result in the observed deficit in the rate of development of allodynia. Deficits in pain-like behaviours have been demonstrated in GFR alpha-2 [16]Nav1.7 [17]Nav1.8 [18,19] and Runx-1 [20] KO mice, although the extent and nature of these behavioural deficits are much more dramatic than those demonstrated with the MrgE KOs, possibly because of complete loss of expression of the genes under study.
###end p 34
###begin p 35
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mrg</italic>
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgF </italic>
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgD </italic>
###xml 118 123 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 277 282 277 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgF </italic>
###xml 316 321 316 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 388 393 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgF </italic>
###xml 411 416 411 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgD </italic>
###xml 469 479 469 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgF MrgE </italic>
###xml 536 541 536 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
The expression of only one Mrg, MrgF was shown to be altered by MrgE deletion. MrgD gene expression was unaffected by MrgE deletion although both these receptors have been shown to functionally associate in a recombinant cell system [12]. Although speculative, upregulation of MrgF may compensate for the absence of MrgE therefore it would be interesting to determine if co-expression of MrgF had any effect on MrgD function, or if the pain behavioural phenotype of an MrgF MrgE double KO would be more profound than that observed with MrgE KOs.
###end p 35
###begin title 36
Conclusion
###end title 36
###begin p 37
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 133 138 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
The data presented in this paper is the first to demonstrate a role for the orphan GPCR MrgE in pain. The functional significance of MrgE deletion on pain will require extension of these studies to detailed molecular and immunohistochemical analysis of the KO mice, and further analysis of the effects of MrgE gene deletion on other pain endpoints and in other pain models.
###end p 37
###begin title 38
Methods
###end title 38
###begin title 39
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Generation of MrgE KO mice
###end title 39
###begin p 40
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 103 108 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 345 350 345 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 133 138 <span type="species:ncbi:10090">mouse</span>
###xml 587 592 <span type="species:ncbi:10090">mouse</span>
MrgE targeted ES clone was obtained from Deltagen (San Carlos, CA.). A genomic fragment containing the MrgE gene was isolated from a mouse genomic phage library. The targeting vector was assembled on the pGT-N28 backbone (NEB, Ipswich, MA) and so designed that a total of 776 bps from within the 930 base pair coding region located in exon 2 of MrgE gene (first exon is un-translated) was deleted and replaced with a 7,076 bp IRES-lacZ reporter and neomycin resistance cassette (IRES-LacZ-NEO) (see Fig. 1A). The targeting vector was linearized and electroporated into the E14 (129/Ola) mouse embryonic stem (ES) cells. ES cells were then cultured in the presence of the antibiotic G418/geneticin, and surviving colonies carrying the homologously integrated neo DNA were identified by PCR amplification, retrieving a 6.5 kb fragment, using a neo-specific reverse primer (#2416, 5'-ATCAGCTTACCATGGCCAAGATCCC-3') paired with a forward primer located 5' to the 5' homology arm (#71732, 5'-GACATCTCCCTAGTCCAGACGACTC-3'). Successful homologous recombination at the 3' end was also confirmed using a neo-specific forward primer (#1431, 5'-ACGTACTCGGATGGAAGCCGGTCTT-3') paired with a reverse primer located 3' to the 3' homology arm (#71738: 5'-CCTCCTTCTCTCTCCACGTGTTCCT-3'), retrieving a 7.0 kb fragment. Colonies that gave rise to the correct PCR products were confirmed by Southern blot analysis and presence of a single neo cassette in the genome was also confirmed by Southern blot analysis using a neo gene fragment as a probe (data not shown).
###end p 40
###begin p 41
###xml 690 695 690 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
Targeted ES cells were injected into C57Bl/6J blastocysts and male chimeric mice were generated and bred with C57Bl/6J female mice to produce F1 heterozygous offspring. F1 germline mice were then bred to C57BL/6J wild type mice to expand the colony and heterozygote mice were interbred to produce the study population mice. All phenotypic analysis was performed on a hybrid C57Bl/6J/129 background. Genotyping to detect wild type, heterozygote and homozygote mice was performed using a multiplex PCR reaction, with a shared 5' forward primer (5'-GCA GAC ATC AGC CAT GAC GT-3') and a 3' reverse primer unique to the targeted allele (#2416, 5'-ATC AGC TTA CCA TGG CCA AGA TCC C-3') or to the MrgE locus (5'-ATC TAT CTC TTG GAT GTG GCC TG-3'). The WT product is 201 and mutant allele 922 bps (see Fig. 1B).
###end p 41
###begin title 42
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Behavioural testing of KO and WT mice
###end title 42
###begin p 43
All animals were handled in accordance with Pfizer policy on animal welfare and with regional government legislation on the use of animals in research.
###end p 43
###begin p 44
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 474 478 <span type="species:ncbi:10090">Mice</span>
The spontaneous locomotor activity of the mice was measured by placing the animals in a novel environment which is monitored for 1 hr in a 35 x 20 cm perspex chamber equipped with a series of two photocells located at 1 and 10 cm above the floor. Each animal was placed in the centre of the cage and total locomotor activity (ambulation and rearing) was monitored every 5 min and recorded as activity counts as the beams were broken. Activity data was captured on computer. Mice were randomly placed in the photo beam equipped cages.
###end p 44
###begin p 45
###xml 74 78 <span type="species:ncbi:10090">Mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
Acute pain responses were assessed using the formalin and hotplate tests. Mice were subjected to the formalin test as follows. Homozygote KO mice and WT littermates were habituated to perspex boxes for 15 minutes before 20 ul of 5% formalin was administered into the plantar surface of the right hind paw. Nocifensive behaviour was assessed by measuring the time spent licking and biting in 5-minute bins for 45 minutes following formalin injection.
###end p 45
###begin p 46
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 219 221 219 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1587 1589 1587 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10090">Mice</span>
###xml 1513 1517 <span type="species:ncbi:10090">mice</span>
###xml 1530 1533 <span type="species:ncbi:10116">rat</span>
Neuropathic pain behaviours in mice were assessed following CCI of the right sciatic nerve based on previously described methods [21]. Mice were placed in an anaesthetic chamber and anaesthetised with a 2% isofluorane O2 mixture. The right hind thigh was shaved and swabbed with 1% iodine. Animals were then transferred to a homeothermic blanket for the duration of the procedure and anaesthesia maintained during surgery via a nose cone. The skin was cut along the line of the thighbone and the common sciatic nerve was exposed at the middle of the thigh by blunt dissection through biceps femoris. Three ligatures (4-0 silk) were tied loosely around the nerve, the wound was closed and the animals allowed to recover. Following surgery the development of static allodynia was monitored regularly over a period of 4 weeks. Static allodynia was evaluated by application of von Frey hairs (Stoelting, Wood Dale, Illinois, U.S.A) in ascending order of force (0.008, 0.02, 0.04, 0.07, 0.16, 0.4, 0.6, 1, 1.4, 2, 4 grams) to the plantar surface of hind paws. Each von Frey hair was applied to the paw for a maximum of 6 seconds, or until a withdrawal response occurred. Once a withdrawal response was established, the paw was re-tested, starting with the filament below. The lowest amount of force required to elicit a response was recorded as paw withdrawal threshold (PWT) in grams. Static allodynia was defined as present if animals responded to a force equal to or less than, 0.04 g, which is innocuous in normal mice. CCI of the rat sciatic nerve was performed as described previously [21].
###end p 46
###begin title 47
Gene expression analysis
###end title 47
###begin p 48
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mrg </italic>
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 897 901 888 890 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 940 946 929 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgC11</italic>
###xml 948 949 937 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 951 953 940 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E </italic>
###xml 957 959 946 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G </italic>
###xml 991 995 980 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgF</italic>
###xml 997 999 986 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H </italic>
###xml 1003 1007 992 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PR4 </italic>
###xml 1131 1144 1111 1124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">(12-(0.3xCt))</sup>
###xml 1235 1237 1215 1217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1678 1683 1658 1663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 1831 1836 1803 1808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MrgE </italic>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 1417 1421 <span type="species:ncbi:10116">rats</span>
###xml 1608 1614 <span type="species:ncbi:10090">murine</span>
###xml 1674 1677 <span type="species:ncbi:10116">rat</span>
Mrg family members and genes important for sensory neuron development and function were quantified in various tissues from adult WT and MrgE KO mice by quantitative RTPCR analysis. DRG, SC and brain tissues (n = 6) were harvested from KO and WT mice, stored in RNAlater (Ambion) at -20degreesC. Tissues were mechanically homogenised using Powergen 125 (Fisher) in 600 ul Buffer RLT (Qiagen) containing beta-Mercaptoethanol (10 ul/ml RLT). SCs and brains were homogenised whole in larger volumes (1.2 ml and 6 ml) accordingly and RNA was extracted as per the RNeasy tissue protocol (Qiagen) with on column DNaseI treatment. Brains and SCs were also treated with Amplification Grade DNaseI (Invitrogen) in accordance with the manufacturer's instructions. RNA was reverse transcribed using the GeneAmp RNA PCR kit (Applied Biosystems) and 15 ng/well equivalent of cDNA used in quantitative PCR TaqMan(R) to determine gene expression levels of MrgC11, D, E and G using custom oligos (Sigma) and MrgF, H and PR4 using Assays on Demandtrade mark (Applied Biosystems). Arbitrary copy number (ACN) was calculated using the formula ACN = 10(12-(0.3xCt)). Multiple gene profiling of the DRGs was performed using 1 ng cDNA per well on a custom RT2 PCR profiler array (SuperArray) and the data analysed using Spotfire Decision site 8.1. The ACN +/-standard deviation was calculated as described. Sciatic nerve was harvested from rats 7, 14 and 21 days post CCI. RNA was isolated from sciatic nerve ipsilateral and contralateral to the injured nerve. cDNA was synthesized from isolated sciatic nerve RNA as described for murine RNA. 25 ng/well of cDNA equivalent was used as template in rat MrgE specific TaqMan assays and the data generated analysed using a DeltaDeltaCt method (Applied Biosystems). Ipsilateral versus contralateral levels of MrgE were compared for each time point post surgery and expressed as relative copy number. The sequences of all primers and probes used in this study are available on request.
###end p 48
###begin title 49
Competing interests
###end title 49
###begin p 50
All authors are employees of Pfizer Global Research and Development and may own/have stock options for Pfizer Inc.
###end p 50
###begin title 51
Authors' contributions
###end title 51
###begin p 52
TP and CHB performed the pain behavioural tests. SAT performed gene expression studies. WQ was involved in coordination of production and genotyping of KO animals. PJC and RAK conceived of the study, and participated in its design and coordination, and drafted the manuscript. All authors read and approved the final manuscript.
###end p 52
###begin title 53
Acknowledgements
###end title 53
###begin p 54
###xml 320 324 <span type="species:ncbi:10090">mice</span>
We would like to acknowledge our colleagues Dic Williams and Laura Corradini for helpful suggestions, Mary K. Bauchmann for expanding the ES clones, Jeffrey L. Stock and Diane M.Z. Nadeau for performing blastocyst injection and Janice B. Drummond, Joanne L. Jeffries-Griffor, and Janis O'Quinn Vajdos for genotyping the mice.
###end p 54
###begin article-title 55
A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons
###end article-title 55
###begin article-title 56
###xml 98 102 <span type="species:ncbi:10116">rats</span>
Sensory neuron-specific receptor activation elicits central and peripheral nociceptive effects in rats
###end article-title 56
###begin article-title 57
###xml 26 32 <span type="species:ncbi:9913">bovine</span>
The involvement of spinal bovine adrenal medulla 22-like peptide, the proenkephalin derivative, in modulation of nociceptive processing
###end article-title 57
###begin article-title 58
###xml 18 21 <span type="species:ncbi:10116">rat</span>
Regulation of two rat mas-related genes in a model of neuropathic pain
###end article-title 58
###begin article-title 59
Topographically distinct epidermal nociceptive circuits revealed by axonal tracers targeted to Mrgprd
###end article-title 59
###begin article-title 60
MrgD activation inhibits KCNQ/M-currents and contributes to enhanced neuronal excitability
###end article-title 60
###begin article-title 61
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 166 169 <span type="species:ncbi:10116">rat</span>
Modulation of ion channels and synaptic transmission by a human sensory neuron-specific G-protein-coupled receptor, SNSR4/mrgX1, heterologously expressed in cultured rat neurons
###end article-title 61
###begin article-title 62
Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors
###end article-title 62
###begin article-title 63
MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion
###end article-title 63
###begin article-title 64
Orphan G protein-coupled receptors MrgA1 and MrgC11 are distinctively activated by RF-amide-related peptides through the Galpha q/11 pathway
###end article-title 64
###begin article-title 65
Recent advances in mammalian RFamide peptides: the discovery and functional analyses of PrRP, RFRPs and QRFP
###end article-title 65
###begin article-title 66
Interactions between the Mas-related receptors MrgD and MrgE alter signalling and trafficking of MrgD
###end article-title 66
###begin article-title 67
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
###xml 63 68 <span type="species:ncbi:9606">human</span>
Cloning and expression of MRG receptors in macaque, mouse, and human
###end article-title 67
###begin article-title 68
The neuropathic pain triad: neurons, immune cells and glia
###end article-title 68
###begin article-title 69
Neuronal mechanism for neuropathic pain
###end article-title 69
###begin article-title 70
###xml 157 161 <span type="species:ncbi:10090">mice</span>
Deficient nonpeptidergic epidermis innervation and reduced inflammatory pain in glial cell line-derived neurotrophic factor family receptor alpha2 knock-out mice
###end article-title 70
###begin article-title 71
Nociceptor-specific gene deletion reveals a major role for Nav17 PN1 in acute and inflammatory pain
###end article-title 71
###begin article-title 72
The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways
###end article-title 72
###begin article-title 73
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Deficits in visceral pain and referred hyperalgesia in Nav18 SNS /PN3-null mice
###end article-title 73
###begin article-title 74
Runx1 determines nociceptive sensory neuron phenotype and is required for thermal and neuropathic pain
###end article-title 74
###begin article-title 75
###xml 70 73 <span type="species:ncbi:10116">rat</span>
Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signalled by distinct primary sensory neurones?
###end article-title 75

